Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.

Revenue
+7.64%
EPS
−12.4%
Free cash flow
−19.4%
Total debt
−10.0%

Quarter to September 2026, against a year earlier

324.26 10.82 −3.23%
Market cap
$127.6B
P/E
35.3×
Fwd P/E
24.6×
Dividend yield
1.05%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100

Stryker Corporation 10-Q filed May 11, 2026

Fiscal Q1 2026 · Period ended Mar 31, 2026 · Filed · accepted 11:10 AM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Oct 31, 2025: 114 added · 180 removed · 81 modified; 42 with only figures updated; 10 moved without change

  1. Removed · ABOUT STRYKER

    Stryker is a global leader in medical technologies and, together